Details for New Drug Application (NDA): 206047
✉ Email this page to a colleague
The generic ingredient in PITAVASTATIN CALCIUM is pitavastatin calcium. There are fifteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pitavastatin calcium profile page.
Summary for 206047
Tradename: | PITAVASTATIN CALCIUM |
Applicant: | Zydus Pharms |
Ingredient: | pitavastatin calcium |
Patents: | 0 |
Pharmacology for NDA: 206047
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Suppliers and Packaging for NDA: 206047
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 206047 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-481 | 68382-481-16 | 90 TABLET in 1 BOTTLE (68382-481-16) |
PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 206047 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-482 | 68382-482-16 | 90 TABLET in 1 BOTTLE (68382-482-16) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Feb 22, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Feb 22, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Feb 22, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription